Abstract
Eleven novel mutations were identified in the NF2 tumour suppressor gene in a panel of British NF2 patients. Screening was performed using a combination of heteroduplex and single-strand conformation polymorphism analysis on polymerase chain reaction amplified material.
This is a preview of subscription content, log in via an institution to check access.
References
Arakawa H, Hayashi N, Nagase H, Ogawa M, Nakamura Y (1994) Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers. Hum Mol Genet 3:565–568
Bianchi AB, Hara T, Ramesh V, Gao J, Klein-Szanto AJP, Morin F, Menon AG, Trofatter JA, Gusella JF, Seizinger B, Kley N (1994) Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types. Nature Genet 6:185–192
Bourn D, Carter SA, Mason S, Evans DGR, Strachan T (1994a) Germline mutations in the NF2 tumour suppressor gene. Hum Mol Genet 3:813–816
Bourn D, Carter SA, Evans DGR, Goodship J, Coakham H, Strachan T (1994b) A mutation in the neurofibromatosis type 2 tumour-suppressor gene, giving rise to widely different clinical phenotypes in two unrelated individuals. Am J Hum Genet 55:69–73
Claudio JO, Marineau C, Rouleau GA (1994) The mouse homologue of the neurofibromatosis type 2 gene is highly conserved. Hum Mol Genet 3:185–190
Conboy J, Kan YW, Shohet SB, Mohandas N (1986) Molecular cloning of protein 4.1, a major structural element of the human erythrocyte membrane skeleton. Proc Natl Acad Sci USA 83:9512–9516
Deprez RHL, Bianchi AB, Groen NA, Seizinger BR, Hagemeijer A, Drunen E van, Bootsma D, Koper JW, Avezaat CJJ, Kley N, Zwarthoff EC (1994) Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet 54:1022–1029
Evans DGR, Huson SM, Donnai D, Neary W, Blair V, Newton V, Harris R (1992) A clinical study of type 2 neurofibromatosis. Q J Med 84:603–618
Funayama N, Nagafuchi A, Sato N, Tsukita S, Tsukita S (1991) Radixin is a novel member of the band 4.1 family. J Cell Biol 115:1039–1048
Gould KL, Bretscher A, Esch FS, Hunter T (1989) cDNA cloning and sequencing of the protein-tyrosine kinase substrate, ezrin, reveals homology to band 4.1. EMBO J 8:4133–4142
Hara T, Bianchi AB, Seizinger B, Kley N (1994) Molecular cloning and characterization of alternatively spliced transcripts of the mouse neurofibromatosis 2 gene. Cancer Res 54:330–335
Irving RM, Moffat DA, Hardy DG, Barton DE, Xuereb JH, Maher ER (1994) Somatic NF2 gene mutations in familial and non-familial vestibular schwannomas. Hum Mol Genet 3:347–350
Jacoby LB, MacCollin M, Louis DN, Mohney T, Rubio M-P, Pulaski K, Trofatter JA, Kley N, Seizinger B, Ramesh V, Gusella JF (1994) Exon scanning for mutation of the NF2 gene in schwannomas. Hum Mol Genet 3:413–419
Lankes WT, Furthmayr H (1991) Moesin: a member of the protein 4.1 talin-ezrin family of proteins. Proc Natl Acad Sci USA 88:8297–8301
MacCollin M, Ramesh V, Jacoby LB, Louis DN, Rubio M, Pulaski K, Trofatter JA, Short MP, Bove C, Eldridge R, Parry DM, Gusella JF (1994) Mutational analysis of patients with neurofibromatosis 2. Am J Hum Genet 55:314–320
Martuza RL, Eldridge R (1988) Neurofibromatosis 2. N Engl J Med 318:684–688
Pykett MJ, Murphy M, Harnish PR, George DL (1994) The neurofibromatosis 2 (NF2) tumour suppressor gene encodes multiple alternatively spliced transcripts. Hum Mol Genet 4:559–564
Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C, Hoang-Xuan K, Demczuk S, Desmaze C, Plougastel B, Pulst SM, Lenoir G, Bijlsma E, Fashold R, Dumanski J, Jong P de, Parry D, Eldridge R, Aurais A, Delattre O, Thomas G (1993) Alteration in a new gene encoding a putative membrane-organising protein causes neurofibromatosis type 2. Nature 363:515–521
Ruttledge MH, Sarrazin J, Rangaratnam S, Phelan CM, Twist E, Merel P, Delattre O, Thomas G, Nordenskjold M, Collins VP, Dumanski JP, Rouleau GA (1994) Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nature Genet 6:180–184
Sainz J, Huynh DP, Figueroa K, Ragge NK, Baser ME, Pulst S-M (1994) Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. Hum Mol Genet 3:885–891
Sato N, Funayama N, Nagafuchi A, Yonemura S, Tsukita S, Tsukita S (1992) A gene family consisting of ezrin, radixin and moesin: its specific localization at actin filament/plasma membrane association sites. J Cell Sci 103:131–143
Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K, Haase VH, Ambrose CM, Munroe D, Bove C, Haines JL, Martuza RL, MacDonald ME, Seizinger BR, Short MP, Buckler AJ, Gusella JF (1993) A novel moesin-ezrin, radixin-like gene is a candidate for the neurofibromatosis 2 tumour suppressor. Cell 72:791–800
Turenen O, Winqvist R, Pakkenen R, Grzeschik KH, Wahlstrom T, Vaheri A (1989) Cytovillin, a microvillar Mr 75,000 protein: cDNA sequence, prokaryotic expression, and chromosomal localization. J Biol Chem 264:16727–16732
Twist EC, Ruttledge MH, Rousseau M, Sanson M, Papi L, Merel P, Delattre O, Thomas G, Rouleau GA (1994) The neurofibromatosis type 2 gene is inactivated in schwannomas. Hum Mol Genet 3:147–151
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bourn, D., Evans, G., Mason, S. et al. Eleven novel mutations in the NF2 tumour suppressor gene. Hum Genet 95, 572–574 (1995). https://doi.org/10.1007/BF00223872
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00223872